Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR)
CUSIP: 12233L206
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share.
- Shares outstanding
- 9,041,375
- Total 13F shares
- 2,034,289
- Share change
- +2,034,289
- Total reported value
- $13,034,824
- Price per share
- $6.45
- Number of holders
- 16
- Value change
- +$13,034,824
- Number of buys
- 16
Quarterly Holders Quick Answers
What is CUSIP 12233L206?
CUSIP 12233L206 identifies BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2024
Recent filing periods for CUSIP 12233L206:
Top shareholders of BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Kynam Capital Management, LP |
13F
|
Company |
107%
|
9,640,914
|
$7,019,549 | — | 31 Mar 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
45%
|
4,026,892
|
$2,931,981 | — | 31 Mar 2024 | |
| FIL Ltd |
13F
|
Company |
31%
|
2,808,981
|
$2,048,309 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
19%
|
1,737,208
|
$1,266,772 | — | 31 Mar 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
6.5%
|
591,428
|
$430,619 | — | 31 Mar 2024 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
6.5%
|
591,428
|
$419,914 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.8%
|
342,700
|
$250,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
3.2%
|
292,868
|
$213,208 | — | 31 Mar 2024 | |
| HSG Holding Ltd |
13F
|
Company |
2.3%
|
212,121
|
$182,212 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.5%
|
223,881
|
$163,008 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.74%
|
66,962
|
$48,829 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.54%
|
49,020
|
$35,745 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.28%
|
25,600
|
$18,667 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.21%
|
19,084
|
$13,916 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
12,558
|
$9,157 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
5,805
|
$4,230 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
1,201
|
$876 | — | 31 Mar 2024 | |
| Neil Nanpeng Shen |
13F
|
Individual |
0.01%
|
885
|
$761 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
83
|
$60 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
65
|
$47 | — | 31 Mar 2024 |
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) as of Q2 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q4 2025 Across Filers
| Investor | Q4 2025 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.